Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TUYA
4276
Tuya Inc
TUYA
$1.1B
| $208K | ﹤0.01% |
+90,646
| New | +$167K |
|
4277
Lexeo Therapeutics
LXEO
$378M
| $208K | ﹤0.01% |
+15,517
| New | +$193K |
|
4278
Descartes Systems
DSGX
$6.82B
| $207K | ﹤0.01% |
2,465
+805
| +48% | +$62.7K |
|
4279
Stoke Therapeutics
STOK
$2.11B
| $207K | ﹤0.01% |
39,271
+30,831
| +365% | +$132K |
|
4280
Acacia Research
ACTG
$470M
| $206K | ﹤0.01% |
52,565
+43,825
| +501% | +$162K |
|
4281
Praxis Precision Medicines
PRAX
$10.1B
| $206K | ﹤0.01% |
+9,245
| New | +$167K |
|
4282
Vanguard Total World Stock ETF
VT
$79.8B
| $206K | ﹤0.01% |
2,000
| – | – |
|
|
IGMS
4283
DELISTED
IGM Biosciences
IGMS
| $204K | ﹤0.01% |
24,570
+17,233
| +235% | +$100K |
|
4284
CAVA Group
CAVA
$7.27B
| $204K | ﹤0.01% |
4,743
-6,239
| -57% | -$218K |
|
|
TSP
4285
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $204K | ﹤0.01% |
231,896
+175,368
| +310% | +$179K |
|
4286
Dakota Gold
DC
$804M
| $203K | ﹤0.01% |
77,584
+67,893
| +701% | +$182K |
|
|
PAMT
4287
PAMT Corp
PAMT
$297M
| $203K | ﹤0.01% |
9,755
+7,549
| +342% | +$147K |
|
4288
The Honest Company
HNST
$586M
| $203K | ﹤0.01% |
61,400
-26,201
| -30% | -$47.8K |
|
|
CUK
4289
DELISTED
Carnival PLC
CUK
| $202K | ﹤0.01% |
12,000
+7,000
| +140% | +$91.6K |
|
4290
CALL
Interparfums
IPAR
$3.94B
| $202K | ﹤0.01% |
+1,400
| New | +$183K |
|
|
4291
PUT
Interparfums
IPAR
$3.94B
| $202K | ﹤0.01% |
+1,400
| New | +$183K |
|
4292
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
| $201K | ﹤0.01% |
1,745
| – | – |
|
|
TUP
4293
DELISTED
Tupperware Brands Corporation
TUP
| $200K | ﹤0.01% |
+100,000
| New | +$181K |
|
4294
BRC Inc
BRCC
$250M
| $200K | ﹤0.01% |
55,094
+48,615
| +750% | +$167K |
|
4295
Lineage Cell Therapeutics
LCTX
$274M
| $200K | ﹤0.01% |
183,292
+159,296
| +664% | +$174K |
|
|
KLG
4296
CALL
DELISTED
WK Kellogg Co
KLG
| $199K | ﹤0.01% |
+15,175
| New | +$171K |
|
4297
Willis Lease Finance
WLFC
$1.29B
| $199K | ﹤0.01% |
12,234
+10,416
| +573% | +$155K |
|
4298
Kimbell Royalty Partners
KRP
$1.48B
| $199K | ﹤0.01% |
13,216
+1,307
| +11% | +$20.5K |
|
4299
iShares Core US Aggregate Bond ETF
AGG
$138B
| $199K | ﹤0.01% |
2,001
-8,859
| -82% | -$843K |
|
4300
Empire Petroleum
EP
$111M
| $198K | ﹤0.01% |
17,978
+15,572
| +647% | +$134K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.